Cefazolin is a semi-synthetic, broad-spectrum cephalosporin antibiotic used to treat infections caused by susceptible bacteria. Its antibacterial mechanism, spectrum, and indications are similar to those of cephalothin. It is less active against Gram-positive bacteria compared to cephalothin but significantly more effective against Gram-negative bacteria, particularly Klebsiella pneumoniae and Escherichia coli. It exhibits strong activity against Streptococcus pneumoniae, second only to penicillin and superior to other antibiotics. Due to its high tissue concentrations in the liver, kidneys, heart, spleen, lungs, and muscles, it is especially indicated for serious infections in these organs. Clinically, it is highly effective in treating respiratory and urinary tract infections.